课题基金 / 基金详情

VACCINATION FOR HIV AND AIDS

VACCINATION FOR HIV AND AIDS
艾滋病毒和艾滋病疫苗接种
批准号:
3547127
负责人:
Murray Briggs Gardner
金额:
$96.54万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-04-01 至 1993-03-31

项目摘要

项目成果

Murray Briggs Gardner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This Program Project is a multidisciplinary coordinated effort aimed at preventing AIDS through development of HIV-1 vaccines. The proposal encompasses the important issues of HIV-1 strain variation and cross-immunogenicity with SIV, the production and composition of conventional and novel HIV immunogens, toxicity tests and induction of HIV-specific humoral and cellular immunity in small animals, and efficacy tests of candidate vaccines in HIV- challenged chimpanzees. Selection of candidate vaccines for efficacy tests in chimps and possible scale up for human use will, thus, be based on a systematic, scientific approach including quantitative estimation of immune response on humoral and cellular levels in guinea pigs and rhesus monkeys. The specific aims of this overall Program Project Grant Proposal are as follows: 1) To compare several HIV-1 strains, selected on the basis of clinical features, biologic properties and serotyping, for toxicity and immunogenicity in guinea pigs and rhesus macaques. 2) Based on results obtained in Aim #1, to develop candidate HIV- 1 vaccine preparations using: a) inactivated whole virus, b) genetically engineered pol mutants, c) recombinant DNA envelope and core subunits expressed in yeast and mammalian cells, and d) effective adjuvants. 3) To test the efficacy of optimum HIV-1 vaccine materials and protocols, chosen on the basis of results obtained above, for protection against HIV-1 challenge in uninfected chimpanzees. This Program Project consists of 5 participating laboratories (Projects I-V) in 4 separate institutions, a) Department of Pathology, University of California, Davis, School of Medicine (UCD)(Project I), b) Tumor Virus Laboratory, Cancer Research Institute, University of California, San Francisco (UCSF)(Project II), c) Chiron Corporation, Emeryville, CA (Project III), d) Liposome Laboratory, Cancer Research Institute (UCSF)(Project IV), and e) Southwest Foundation for Biomedical Research, San Antonio, Texas (Project V). We believe this consortium makes sense by providing the scientific talent, unique resources and administrative competence to carry out the teamwork necessary to accomplish the stated objectives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NUCLEIC ACID VACCINATION AGAINST SIV (2)
  • 批准号:
    6277910
  • 项目类别:
  • 资助金额:
    $8.13万
  • 财政年份:
    1998
  • 负责人:
    Murray Briggs Gardner
  • 依托单位:
NUCLEIC ACID VACCINATION AGAINST SIV
  • 批准号:
    6277911
  • 项目类别:
  • 资助金额:
    $8.13万
  • 财政年份:
    1998
  • 负责人:
    Murray Briggs Gardner
  • 依托单位:
GENETIC IMMUNIZATION FOR LENTIVIRAL IMMUNODEFICIENCY VIRUS INFECTION & DISEASE
  • 批准号:
    6247784
  • 项目类别:
  • 资助金额:
    $8.94万
  • 财政年份:
    1997
  • 负责人:
    Murray Briggs Gardner
  • 依托单位:
SIV & HIV TRANSMEMBRANE SUBUNIT OF ENV IN AIDS
  • 批准号:
    6247785
  • 项目类别:
  • 资助金额:
    $8.94万
  • 财政年份:
    1997
  • 负责人:
    Murray Briggs Gardner
  • 依托单位:
海外基金